4.6 Article

Inhibition of Macrophage CD36 Expression and Cellular Oxidized Low Density Lipoprotein (oxLDL) Accumulation by Tamoxifen: A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR)-DEPENDENT MECHANISM

Related references

Note: Only part of the references are listed.
Article Hematology

Inhibition of ERK1/2 and Activation of LXR Synergistically Reduce Atherosclerotic Lesions in ApoE-Deficient Mice

Yuanli Chen et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)

Article Biochemistry & Molecular Biology

Rapamycin-mediated CD36 translational suppression contributes to alleviation of hepatic steatosis

Chuan Wang et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)

Review Oncology

Tamoxifen as the first targeted long-term adjuvant therapy for breast cancer

V. Craig Jordan

ENDOCRINE-RELATED CANCER (2014)

Article Biochemistry & Molecular Biology

Tamoxifen inhibits macrophage FABP4 expression through the combined effects of the GR and PPARγ pathways

Meixiu Jiang et al.

BIOCHEMICAL JOURNAL (2013)

Article Biochemistry & Molecular Biology

Activation of Liver X Receptor Induces Macrophage Interleukin-5 Expression

Yuanli Chen et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2012)

Article Cardiac & Cardiovascular Systems

Induction of macrophage scavenger receptor type BI expression by tamoxifen and 4-hydroxytamoxifen

Pengzhi Dong et al.

ATHEROSCLEROSIS (2011)

Review Endocrinology & Metabolism

Molecular therapy of breast cancer: progress and future directions

Sheng-Xiang Lin et al.

NATURE REVIEWS ENDOCRINOLOGY (2010)

Review Biochemistry & Molecular Biology

CD36, a Scavenger Receptor Involved in Immunity, Metabolism, Angiogenesis, and Behavior

Roy L. Silverstein et al.

SCIENCE SIGNALING (2009)

Article Cell Biology

A CD36-dependent signaling cascade is necessary for macrophage foam cell formation

S. Ohidar Rahaman et al.

CELL METABOLISM (2006)

Article Medicine, Research & Experimental

Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARα, β/δ, and β

AC Li et al.

JOURNAL OF CLINICAL INVESTIGATION (2004)

Article Cardiac & Cardiovascular Systems

Synergistic upregulation of low-density lipoprotein receptor activity by tamoxifen and lovastatin

Y Suárez et al.

CARDIOVASCULAR RESEARCH (2004)

Article Cardiac & Cardiovascular Systems

Tamoxifen improves endothelial function and reduces carotid intima-media thickness in postmenopausal women

KS Stamatelopoulos et al.

AMERICAN HEART JOURNAL (2004)

Review Multidisciplinary Sciences

Inflammation in atherosclerosis

P Libby

NATURE (2002)

Article Cardiac & Cardiovascular Systems

Influence of tamoxifen on carotid intima-media thickness in postmenopausal women

T Simon et al.

CIRCULATION (2002)

Article Medicine, Research & Experimental

CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism

M Febbraio et al.

JOURNAL OF CLINICAL INVESTIGATION (2001)

Review Biochemistry & Molecular Biology

Atherosclerosis: The road ahead

CK Glass et al.

Article Biochemistry & Molecular Biology

A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis

A Chawla et al.

MOLECULAR CELL (2001)

Article Medicine, Research & Experimental

Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice

M Febbraio et al.

JOURNAL OF CLINICAL INVESTIGATION (2000)